Category: Therapeutics

Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study

RACE Act: A Promising Catalyst for Improved Pediatric Cancer Treatments

Moderna Completes Enrollment of Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273)

Mitigating Impacts of a Global Pandemic in the Clinical Development Space

UK Achieves Site Activation World Record for Roche During COVID-19 Pandemic

PPD Heroes: We’re in This Together

How COVID-19 is Changing the Approach for the Vaccine Development Process

Moderna Announces Phase 3 COVE Study of mRNA Vaccine Against COVID-19 (mRNA-1273) Begins

Implementing the Estimands Framework in Clinical Trials